EPO and anemia (phenotype): FGF23 may aggravate anemia through direct mechanisms, such as suppressing erythropoietin secretion and inducing red blood cell apoptosis, and indirect mechanisms, including effects on iron metabolism via inflammatory cytokine induction [75,76].